These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma. Yoshizawa N, Sugimoto K, Tameda M, Inagaki Y, Ikejiri M, Inoue H, Usui M, Ito M, Takei Y. Oncol Lett; 2020 Apr 02; 19(4):2677-2684. PubMed ID: 32218818 [Abstract] [Full Text] [Related]
7. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. Wang C, Sun Y, Wu H, Yu S, Zhang L, Meng Y, Liu M, Yang H, Liu P, Mao X, Lu Z, Chen J. Tumour Biol; 2015 Dec 02; 36(12):9447-56. PubMed ID: 26124009 [Abstract] [Full Text] [Related]
9. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Kong X, Du Y, Wang G, Gao J, Gong Y, Li L, Zhang Z, Zhu J, Jing Q, Qin Y, Li Z. Dig Dis Sci; 2011 Feb 02; 56(2):602-9. PubMed ID: 20614181 [Abstract] [Full Text] [Related]
10. Extracellular vesicles microRNA analysis in type 1 autoimmune pancreatitis: Increased expression of microRNA-21. Nakamaru K, Tomiyama T, Kobayashi S, Ikemune M, Tsukuda S, Ito T, Tanaka T, Yamaguchi T, Ando Y, Ikeura T, Fukui T, Nishio A, Takaoka M, Uchida K, Leung PSC, Gershwin ME, Okazaki K. Pancreatology; 2020 Apr 02; 20(3):318-324. PubMed ID: 32147308 [Abstract] [Full Text] [Related]
14. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Munding JB, Adai AT, Maghnouj A, Urbanik A, Zöllner H, Liffers ST, Chromik AM, Uhl W, Szafranska-Schwarzbach AE, Tannapfel A, Hahn SA. Int J Cancer; 2012 Jul 15; 131(2):E86-95. PubMed ID: 21953293 [Abstract] [Full Text] [Related]
15. MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer. Yang JY, Sun YW, Liu DJ, Zhang JF, Li J, Hua R. Am J Cancer Res; 2014 Jul 15; 4(6):663-73. PubMed ID: 25520858 [Abstract] [Full Text] [Related]
16. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients. Sun B, Liu X, Gao Y, Li L, Dong Z. Br J Biomed Sci; 2016 Oct 15; 73(4):152-157. PubMed ID: 27922430 [Abstract] [Full Text] [Related]
18. Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis. Maekawa T, Kamada Y, Ebisutani Y, Ueda M, Hata T, Kawamoto K, Takamatsu S, Mizutani K, Shimomura M, Sobajima T, Fujii H, Nakayama K, Nishino K, Yamada M, Kumada T, Ito T, Eguchi H, Nagano H, Miyoshi E. World J Gastroenterol; 2016 May 07; 22(17):4403-10. PubMed ID: 27158210 [Abstract] [Full Text] [Related]
19. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile. Cote GA, Gore AJ, McElyea SD, Heathers LE, Xu H, Sherman S, Korc M. Am J Gastroenterol; 2014 Dec 07; 109(12):1942-52. PubMed ID: 25350767 [Abstract] [Full Text] [Related]